Oxygenta Pharmaceutical Limited announced a private placement of of up to 7,395,000 equity shares on preferential basis on February 27, 2023. The transaction will include participation from Suneel Vishram Chawda for 3,180,000, Manoj Sunil Chawda for 1,582,500, Akanksha Manoj Chawda for 1,582,500 shares, Gunreddy Krishna Reddy, Vangala Syam Sunder Reddy, Srinivas Rao Garlapati for 150,000 shares each, Paturi Sai Sampath for 100,000 and Sanagari Kondal Reddy for 500,000 shares. The price will not being lower than the price determined in accordance with the Chapter V of SEBI ICDR Regulations, 2018 and other applicable regulations if any.